EU-UK Trade Deal Allows For Mutual Recognition Of GMP Inspections
But No MRA For Batch Testing And Release
The trade deal agreed by the EU and the UK may have brought some relief to the life sciences sector in that it averts the chaos that would have followed failure to reach a deal, but it contains little that will have a direct impact on the regulation of medicines.
You may also be interested in...
There may not be a great deal in the new UK-EU trade and cooperation deal for the life sciences industry but a new working group could act as the forum for constructive discussions on regulatory cooperation.
UK consumer health industry association PAGB says it is "relieved" a last minute post-Brexit deal has been struck, which will enable its members to continue to supply OTCs to the EU with limited disruption.
The devil will be in the detail but the UK/EU industry's first reaction to the last-minute post-Brexit trade deal is one of relief.